Publications
Some examples of my work
Cited for publication management or editorial support:
Partouche N, et al. Does the IL-6/KL-6 ratio distinguish different phenotypes in COVID-19 Acute Respiratory Distress Syndrome? An observational study stemmed from prospectively derived clinical, biological, and computed tomographic data.
PLOS ONE. 2025; 20(5): e0321533.
Buch MH, et al. Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate.
Rheumatology (Oxford). 2025 Apr 1;64(4):1661-1671.
Mariette X, et al. Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes.
RMD Open 2025;11:e005033
Westhovens R, et al. Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study.
RMD Open 2025;11:e004857
Buch MH, et al. Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study.
RMD Open 2024;10:e004476
Paumier A, et al. Anti-oxidant Effect of High Dilutions of Arnica montana, Arsenicum Album, and Lachesis Mutus in Microglial Cells in Vitro.
Dose-Response. 2022;20(2).
Ludes P-O, et al. Role of damage-associated molecular patterns in septic acute kidney injury, from injury to recovery.
Front Immunol. 2021. 12:606622.
Pottecher J, et al. Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients.
Trials. 2020; 21:274.
Vincent P, et al. Intra-articular hyaluronic acid for knee osteoarthritis: a postmarket, open-label, long-term historical control study with analysis detailed per Krellgren-Lawrence radiologic osteoarthritis scale grade.
Curr Ther Res Clin Exp. 2020; 92: 100575.
Vincent P. Intra-articular hyaluronic acid in the symptomatic treatment of knee osteoarthritis: a meta-analysis of single-injection products.
Curr Ther Res Clin Exp. 2019; 90: 39-51.
Fleischer DM, et al. Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy. The PEPITES randomized clinical trial.
JAMA. 2019; 321(10): 946-955.
Rabaa MA, et al. Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy.
eLife2017;6:e24196.
L'Azou M, et al. Symptomatic dengue in children in 10 Asian and Latin American countries.
Engl J Med. 2016; 374:1155-1166.
Coudeville L, et al. Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies.
Vaccine. 2016; 34: 6417-6425.
Coudeville L, et al. Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine.
Vaccine. 2016; 34: 6426-6435.
Harenberg A, et al. Cytokine profile of children hospitalised with virologically-confirmed dengue during two phase III vaccine efficacy trials.
PLoS Negl Trop Dis. 2016; 10(7):e0004830.
Byers AM, et al. Influence of FcγRIIa-expressing cells on the assessment of neutralizing and enhancing serum antibodies elicited by a live-attenuated tetravalent dengue vaccine.
Open Forum Infect Dis. 2015; 2(4): ofv172.